Skip to main content

NeuroBytes: Treatment Strategies for MOG Antibody Associated Disease: Current Practice and Clinical Trials

NeuroBytes: Treatment Strategies for MOG Antibody Associated Disease: Current Practice and Clinical Trials

Course Description

Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is an inflammatory disease of the central nervous system driven by antibody-mediated demyelination. Until recently, it was often diagnosed as multiple sclerosis or seronegative neuromyelitis optica. With the availability of cell-based assays for detection of MOG serum autoantibodies in 2018, MOGAD became recognized as a distinct entity with publication of its first diagnostic criteria in 2023. While there is currently no FDA approved medication for MOGAD yet, various clinical trials are underway.

Learning Objectives

As a result of this program the learner will be able to:
  • Describe the diagnostic criteria and treatment approach to MOGAD.

Date of Release

May 10, 2024

Confidentiality of Data

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete Terms of Use.

Faculty & Disclosures


JIYEON SON, MD
Columbia University Medical Center
New York, NY
*Dr. Son has nothing to disclose.

Editor

REBECCA G. STRAUS FRABER, MD
Columbia University Medical School
New York, NY
Dr. Straus Farber has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Straus Farber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for FKB Law. The institution of Dr. Straus Farber has received research support from Biogen. The institution of Dr. Straus Farber has received research support from Novartis.


Reviewer

ADAM QUICK, MD
Associate Professor of Neurology
The Ohio State university Wexner Medical Center
Columbus, OH
*Dr. Quick has nothing to disclose.

Voiceover Artist

BEN STODDART
Senior Trainee Education Administrator
Minneapolis, MN
*Mr. Stoddart has nothing to disclose



NeuroBytes Staff

Xiaoyu Sun, Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.


Robert Rook, Manager, eLearning
Minneapolis, MN
*Mr. Rook has nothing to disclose.